Search

Author/Creator In, Changhoon

1. 592 Enhancing the therapeutic potential of oncolytic adenoviruses with vSENS™ technology. (10th December 2020)

Authors:
Kim, Goo-Young; Son, Ji Yeon; Lee, So Jin; Jo, Sang Woo; In, Changhoon; Kim, Sang Hoon; Park, Joon Young; Kim, So-Young; Moon, Gyu-Young; Choi, Ji-Hye; Kim, Suk-Hwan; Yun, Minhyuk; Nam, Hye Yeong; Cho, Helen
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A354
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 592 Enhancing the therapeutic potential of oncolytic adenoviruses with vSENS™ technology. (9th November 2020)

Authors:
Kim, Goo-Young; Son, Ji Yeon; Lee, So Jin; Jo, Sang Woo; In, Changhoon; Kim, Sang Hoon; Park, Joon Young; Kim, So-Young; Moon, Gyu-Young; Choi, Ji-Hye; Kim, Suk-Hwan; Yun, Minhyuk; Nam, Hye Yeong; Cho, Helen
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A627
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 734 A novel NQO1 specific anti-tumor agent, SBSC-S3001, selectively regresses the growth of tumors with high NQO1 expression. (9th November 2020)

Authors:
Yun, Minhyuk; Kim, Goo-Young; Jo, Sang Woo; In, Changhoon; Moon, Gyu-Young; Ko, In Seok; Lee, Eun Ju; Hong, Yong Rae; Lee, Whee Seong; Cho, Helen
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A778
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search